Cetera Advisors LLC Novo Nordisk A S Transaction History

Cetera Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $3.36 Million - $4.47 Million	32,862 Added 106.8%	63,633 $8.17 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $982,872 - $1.18 Million	11,197 Added 57.2%	30,771 $3.18 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $667,408 - $1.46 Million	7,339 Added 59.98%	19,574 $1.78 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $620,956 - $687,319	3,981 Added 48.23%	12,235 $1.98 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $124,134 - $149,273	938 Added 12.82%	8,254 $1.31 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $750,255 - $990,074	7,316 New	7,316 $990,000

1,952

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.